A single-center experience of non-bioartificial liver support systems among Chinese patients with liver failure

Abstract

NBAL treatment is helpful to improve the survival of patients with ALF, SALF or ACLF. ACLF patients with lower MELD scores showed improved outcomes relative to those with higher MELD scores.